X0306 4 2018-02-23 0 0001717452 Odonate Therapeutics, Inc. ODT 0001178579 TANG KEVIN C 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 1 1 1 0 Chief Executive Officer 0001191935 TANG CAPITAL PARTNERS LP 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 0 0 1 0 0001232621 TANG CAPITAL MANAGEMENT LLC 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 0 0 1 0 0001495904 Lemkey John G 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Common Stock 2018-02-23 4 P 0 2175 27.9938 A 12371851 I By LP Common Stock 2018-02-26 4 P 0 487 28.00 A 12372338 I By LP Common Stock 2018-02-26 4 P 0 10000 27.7048 A 12382338 I By LP Common Stock 2018-02-26 4 P 0 3359 27.3244 A 12385697 I By LP Common Stock 2018-02-27 4 P 0 6641 27.2615 A 12392338 I By LP Common Stock 2018-02-27 4 P 0 5950 26.9313 A 12398288 I By LP The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin C. Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. The shares reported as beneficially owned by TCP include a total of 154,285 shares of common stock that are held of record by Odonate Holdings, LLC ("Holdings"). Holdings has granted a proxy to TCP giving TCP the sole authority to vote such shares. John G. Lemkey is the Chief Financial Officer of Odonate Therapeutics, Inc., as well as Chief Operating Officer of TCM. Mr. Lemkey has a pecuniary interest in a portion of the shares beneficially held by TCP. /s/ Kevin C. Tang 2018-02-27 /s/ Kevin C. Tang, Managing Member of Tang Capital Management, LLC, General Partner 2018-02-27 /s/ Kevin C. Tang, Managing Member 2018-02-27 /s/ John G. Lemkey 2018-02-27